Jar-Yi Ho

5PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 17, 2026
Association of Postoperative Antidepressant and Anxiolytic Exposure With Overall Survival Following Radical Cystectomy for Bladder Cancer.

|Jul 15, 2026
Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells.

|Aug 13, 2025
Fucoidan Modulates Osteoarthritis Progression Through miR-22/HO-1 Pathway.

Tsung-Hsun Hsieh, Jar-Yi Ho, Chih-Chien Wang

|Feb 25, 2022
Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer.

Cheng-Shuo Huang, Chen-Hua Tsai, Cheng-Ping Yu

|Apr 30, 2021
Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters.

Ying-Si Wu, Jar-Yi Ho, Cheng-Ping Yu

Pageof 1

Frequent Collaborators

3 joint publications

Cheng-Ping Yu

2 joint publications

Cheng-Shuo Huang

1 joint publications

Chih-Chien Wang

1 joint publications

Yi-Jen Peng